Access cutting-edge breast cancer treatment through this clinical trial at a research site in Arcadia. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Arcadia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This is a multicenter, Phase 1b/2 trial in participants with estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the recommended Phase 2 dose (RP2D) of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, capivasertib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations.
Sponsor: Stemline Therapeutics, Inc.
Check if you qualify for this breast cancer clinical trial in Arcadia, CA
If you're searching for breast cancer treatment options in Arcadia, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Arcadia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.